Table 2.
Coronary angiographic features and PCI procedural details and complications
| Features | Diabetic patients (N = 1300) (%) | Nondiabetic patients (N = 1126) (%) | p value |
|---|---|---|---|
| Coronary artery disease | |||
| One vessel | 55.4 | 61.8 | 0.002 |
| Multivessel | 42.7 | 37.0 | 0.005 |
| LM | 1.9 | 1.2 | 0.22 |
| PCI performed for | |||
| One vessel | 68.6 | 74.5 | 0.002 |
| Multivessel | 29.7 | 25.0 | 0.011 |
| LM | 1.7 | 0.5 | 0.014 |
| Indication for PCI | |||
| ACS | 76.3 | 78.5 | 0.214 |
| STEMI | 27.5 | 33.7 | 0.001 |
| NSTEACS | 48.8 | 44.8 | 0.054 |
| Chronic stable disease | 23.7 | 21.5 | 0.214 |
| Types of stents | |||
| BMS | 8.6 | 10.8 | 0.078 |
| Second-generation DES | 90.6 | 88.1 | 0.053 |
| BVS | 0.8 | 1.1 | 0.58 |
| PCI complications | |||
| Ventricular tachyarrhythmia | 0.8 | 1.0 | 0.760 |
| Heart failure | 9.2 | 6.7 | 0.029 |
| Cardiogenic shock | 0.8 | 0.3 | 0.173 |
| Coronary dissection | 0.6 | 1.3 | 0.113 |
| Emergency CABG | 0 | 0.3 | 0.153 |
Chi-square test was used to test differences between proportions in diabetic and nondiabetic patients
ACS acute coronary syndrome, BMS bare metal stent, BVS bioresorbable scaffold, CABG coronary artery bypass graft surgery, DES drug-eluting stent, LM left main coronary artery, NSTEACS non-ST-segment elevation ACS, PCI percutaneous coronary intervention, STEMI ST segment elevation myocardial infarction